Literature DB >> 4194305

Genetic control of the specificity of anti-DNP antibodies. II. Differences in the specificity of anti-DNP antibody produced by several inbred strains of mice.

W E Paul, T Yoshida, B Benacerraf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4194305

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

Review 1.  Antibody affinity: immunogenetic aspects and relationship to immune complex disease.

Authors:  M W Steward
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  The heterogeneity of antibody affinity in inbred mice and its possible immunopathologic significance.

Authors:  R E Petty; M W Steward; J F Soothill
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

3.  The immunopathological significance of the heterogeneity of antibody affinity.

Authors:  J F Soothill; M W Steward
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

4.  Studies on the control of antibody synthesis. VII. Change in affinity of direct and indirect plaque-forming cells with time after immunization in the mouse: loss of high affinity plaques late after immunization.

Authors:  E A Goidl; J J Barondess; G W Siskind
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

5.  Influence of mouse strain on the assayed potency (unitage) of tetanus toxoid.

Authors:  M C Hardegree; M Pittman; C J Maloney
Journal:  Appl Microbiol       Date:  1972-07

6.  Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H2-linked genes in the control of the anti-nuclease antibody response.

Authors:  D S Pisetsky; J A Berzofsky; D H Sachs
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

7.  Inheritance of antibody specificity. I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response.

Authors:  T Imanishi; O Mäkelä
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.